Table 3

Number of observed and expected cancers from 1978 to 2009 in the study population, for both sexes, according to the CEI for asbestos

SexLocalisationCEI ≤80 fibres/mL×yearsCEI>80 fibres/mL×years
ObservedExpectedSIRObservedExpectedSIR
(95% CI)(95% CI)
MenAnal canal00.17NC10.362.78 (0.04 to 15.5)
Biliary tract10.422.38 (0.03 to 13.2)30.993.03 (0.61 to 8.86)
Colon–rectum97.671.17 (0.54 to 2.23)2418.31.31 (0.84 to 1.95)
Stomach32.561.17 (0.23 to 3.42)96.521.38 (0.63 to 2.62)
Liver32.861.05 (0.21 to 3.06)156.892.18 (1.22 to 3.59)
Small intestine00.21NC30.466.50 (1.31 to 19.0)
Peritoneum00.07NC30.1519.5 (3.93 to 57.1)
Oesophagus54.421.13 (0.36 to 2.64)2010.51.90 (1.16 to 2.94)
Other00.16NC00.38NC
Pancreas21.691.18 (0.13 to 4.27)53.971.26 (0.41 to 2.94)
Digestive excluding mesothelioma2320.21.14 (0.72 to 1.71)8048.41.65 (1.31 to 2.06)
All digestive2320.21.14 (0.72 to 1.71)8348.51.71 (1.36 to 2.12)
WomenAnal canal00.11NC00.18NC
Biliary tract00.13NC00.25NC
Colon–rectum21.571.27 (0.14 to 4.60)42.921.37 (0.37 to 3.50)
Stomach00.33NC10.671.49 (0.02 to 8.32)
Liver10.156.70 (0.09 to 37.3)00.24NC
Small intestine00.05NC00.08NC
Peritoneum00.05NC50.0774.8 (24.1 to 174)
Oesophagus00.18NC00.21NC
Other00.03NC00.06NC
Pancreas00.34NC00.58NC
Digestive excluding mesothelioma32.851.05 (0.21 to 3.08)55.190.96 (0.31 to 2.25)
All digestive32.901.04 (0.21 to 3.03)105.261.9 (0.91 to 3.50)
  • CEI, Cumulative Exposure Index; NC, non-calculated; SIR, Standardised Incidence Ratio.